This review summarizes the major functions and regulatory mechanisms of KLF4 in ten common cancers in an attempt to discover its unique tumor regulatory role, and propose KLF4 as a potential therapeutic target and clinical biomarker in tumors, especially pancreatic cancer (PDA). Here, KLF4 is linked to Patent ductus arteriosus.